Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease.
Saved in:
| Title: | Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease. |
|---|---|
| Authors: | Singh B; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA.; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Gonzalez Suarez ML; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA., Baweja R; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA., Abulseoud OA; Department of Psychiatry and Psychology, Mayo Clinic Arizona, Phoenix, AZ, USA., Saunders EFH; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA., Baweja R; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA. |
| Source: | Therapeutic advances in psychopharmacology [Ther Adv Psychopharmacol] 2026 Feb 20; Vol. 16, pp. 20451253261423437. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101555693 Publication Model: eCollection Cited Medium: Print ISSN: 2045-1253 (Print) Linking ISSN: 20451253 NLM ISO Abbreviation: Ther Adv Psychopharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-1253 |
|---|---|
| DOI: | 10.1177/20451253261423437 |